Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim

Transfusion

Volumn 37, Issue 5, 1997, Pages 507-512

  Anderlini, P ^a,b   Przepiorka, D ^a,c   Seong, C ^a,c,d   Smith, T L ^a,c   Huh, Y O ^a,c   Lauppe, J ^a,c   Champlin, R ^a,c   Korbling M ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b Department of Hematology ^*  (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGE; AGED; APHERESIS; ARTICLE; BLOOD DONOR; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PREDICTION; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030954443     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37597293882.x     Document Type: Article

References (33)

1. Körbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995;85:1659-65.
2. Bensinger WI, Weaver CH, Appelbaum FR, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995;85:1655-8.
3. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995;85:1666-72.
4. Russell JA, Luider J, Weaver M, et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995;15:111-5.
5. Azevedo WM, Aranha FJ, Gouvea JV, et al. Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies. Bone Marrow Transplant 1995;16:647-53.
6. Anderlini P, Przepiorka D, Seong D, et al. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedure. Transfusion 1996;36:590-5.
7. Stroncek D, Clay M, Mills B, et al. Experiences of normal individuals treated with granulocyte colony-stimulating factor (abstract). Blood 1994;84:349a.
8. Grigg AP, Roberts AW, Raunow H, et al. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995;86:4437-45.
9. Weaver CH, Buckner CD, Longin K, et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after administration of recombinant human granulocyte colony-stimulating factor. Blood 1993;82:1981-4.
10. +progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation. Br J Haematol 1996;93:940-2.
11. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995;13:2547-55.
12. Haas R, Möhle R, Frühauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787-94.
13. Tanaka R, Matsudaira T, Aizawa J, et al. Characterization of peripheral blood progenitor cells (PBPC) mobilized by filgrastim (rHuG-CSF) in normal volunteers: dose-effect relationship for filgrastim with the character of mobilized PBPC. Br J Haematol 1996;92:795-803.
14. Höglund M, Bengtsson M, Simonsson B, et al. Leukapheresis with peripheral blood progenitor cell (PBPC) harvest in healthy volunteers receiving different doses of lenograstim - evidence of a dose response effect (abstract). Blood 1994;84:348a.
15. Höglund M, Bengtsson M, Cour-Chabernaud V, et al. Glycosylated rHuG-CSF is more potent than non-glycosylated rHuG-CSF in mobilisation of peripheral blood progenitor cells (PBPC) in healthy volunteers (abstract). Blood 1995;86:464a.
16. Andrews RG, Briddell RA, Knitter GH, et al. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 1995;85:15-20.
17. Geissler K, Peschel C, Niederwieser D, et al. Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3. Blood 1996;87:2732-9.
18. 4 integrin. Proc Natl Acad Sci U S A 1993;90:9374-8.
19. Fruehauf S, Haas R, Conradt C, et al. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF) -supported cytotoxic chemotherapy. Blood 1995;85:2619-26.
20. Schwella N, Beyer J, Schwaner I, et al. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol 1996;14:1114-21.
21. Schots R, Van Riet I, Damiaens S, et al. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996;17:509-15.
22. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995;86:2842-8.
23. Azuma J, Kurimoto T, Awata S, et al. Phase I study of KRN 8601 (rhG-CSF) in normal healthy volunteers: safety and pharmacokinetics in single subcutaneous administration. Rinsho Iyaku 1989;5:2231-52.
24. Zaino EC. Blood counts in the nonagenarian. N Y State J Med 1981;81:1199-200.
25. Hartsock RJ, Smith EB, Petty CS. Normal variations with aging on the amount of hematopoietic tissue in bone marrow from the anterior iliac crest. Am J Clin Pathol 1965:43:326-31.
26. Lipschitz DA, Udupa KB, Milton KY, Thompson CO. Effect of age on hematopoiesis in man. Blood 1984;63:502-9.
27. Buckner CD, Clift RA, Sanders JE, et al. Marrow harvesting from normal donors. Blood 1984;64:630-4.
28. Timaffy M. A comparative study of bone marrow function in young and old individuals. Gerontol Clin 1962;4:13-18.
29. Cream JJ. Prednisolone-induced granulocytosis. Br J Haematol 1968;15:259-67.
30. Chatta GS, Andrews RG, Rodger E, et al. Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3. J Gerontol 1993;48:M207-12.
31. Dreger P, Haferlach T, Eckstein V, et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994;87:609-13.
32. Chatta GS, Price TH, Allen RC, Dale DC. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood 1994;84:2923-9.
33. Goodnough LT, Brown R, Adkins D, DiPersio J. An analysis of "elderly" (age>50 years) allogeneic stem cell pheresis donors (abstract). Blood 1995;86:580a.